https://www.fiercebiotech.com/partnering/abbvie-ties-knot-infinity-805m-blood-cancer-collaboration
AbbVie ties the knot with Infinity in $805M blood cancer collaboration | Fierce Biotech
Sep 3, 2014 - AbbVie has agreed to hand over $275 million upfront to Infinity Pharmaceuticals in exchange for rights to develop and commercialize duvelisib, its oral...